Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 9 de 9
Filtre
1.
Indian Heart J ; 2022 Oct; 74(5): 351-356
Article | IMSEAR | ID: sea-220924

Résumé

Aims: IMPROVE Brady assessed whether a process improvement intervention could increase adoption of guideline-based therapy in sinus node dysfunction (SND) patients. Methods: /Results: IMPROVE Brady was a sequential, prospective, quality improvement initiative conducted in India and Bangladesh. Patients with symptomatic bradycardia were enrolled. In Phase I, physicians assessed and treated patients per standard care. Phase II began after implementing educational materials for physicians and patients. Primary objectives were to evaluate the impact of the intervention on SND diagnosis and pacemaker (PPM) implant. SF-12 quality of life (QoL) and Zarit burden surveys were collected pre- and post-PPM implant. A total of 978 patients were enrolled (57.7 ± 14.8 years, 75% male), 508 in Phase I and 470 in Phase II. The diagnosis of SND and implantation of PPM increased significantly from Phase I to Phase II (72% vs. 87%, P < 0.001 and 17% vs. 32%, P < 0.001, respectively). Pacemaker implantation was not feasible in 41% of patients due to insurance/cost barriers which was unaltered by the intervention. Both patient QoL and caregiver burden improved at 6-months post-PPM implant (P < 0.001). Conclusions: A process improvement initiative conducted at centers across India and Bangladesh significantly increased the diagnosis of SND and subsequent treatment with PPM therapy despite the socio-economic constraints.

2.
Indian Heart J ; 2022 Jun; 74(3): 194-200
Article | IMSEAR | ID: sea-220894

Résumé

Aims: Sudden cardiac death (SCD) continues to be a devastating complication amongst survivors of myocardial infarction (MI). Mortality is high in the initial months after MI. The aims of the INSPIRE-ELR study were to assess the proportion of patients with significant arrhythmias early after MI and the association with mortality during 12 months of follow-up. Methods: The study included 249 patients within 14 days after MI with left ventricular ejection fraction (LVEF) _x0001_35% at discharge in 11 hospitals in India. Patients received a wearable external loop recorder (ELR) 5 ± 3 days after MI to monitor arrhythmias for 7 days. Results: Patients were predominantly male (86%) with a mean age of 56 ± 12 years. In 82%, reperfusion had been done and all received standard of care cardiovascular medications at discharge. LVEF was 32.2 ± 3.9%, measured 5.1 ± 3.0 days after MI. Of the 233 patients who completed monitoring (7.1 ± 1.5 days), 81 (35%) experienced significant arrhythmias, including Ventricular Tachycardia/Fibrillation (VT/ VF): 10 (4.3%); frequent Premature Ventricular Contractions (PVCs): 65 (28%); Atrial Fibrillation (AF): 8 (3.4%); chronic atrial flutter: 4 (1.7%); 2nd or 3rd degree Atrioventricular (AV) block: 4 (1.7%); and symptomatic bradycardia: 8 (3.4%). In total, 26 patients died. Mortality was higher in patients with clinically significant arrhythmia (at 12 months: 23.6% vs 4.8% with 19 vs 7 deaths, hazard ratio (HR) ¼ 5.5, 95% confidence interval (CI) 2.3 to 13.0, p < 0.0001). Excluding 7 deaths during ELR monitoring, HR ¼ 4.5, p < 0.001. Conclusion: ELR applied in patients with acute MI and LV dysfunction at the time of discharge identifies patients with high mortality risk.

3.
Article | IMSEAR | ID: sea-184823

Résumé

The purpose of this paper is: To introduce a novel surgical technique of reduction clitoroplasty. In this study, ten patients, known cases of congenital adrenal hyperplasia with clitoromegaly were operated for reduction clitoroplasty. In our technique, the phallus was degloved till the base and plicating sutures were taken from the base of crura to the shaft of the clitoris to the subcoronal mucosa. It was observed that this technique had good cosmetic results and patient satisfaction.

4.
Article | IMSEAR | ID: sea-184949

Résumé

This is a case series of 3 neonates with features of acute abdomen. The first neonate presented on day 6 of life with convulsions and fever. He developed abdominal distension and had bilious vomiting by day 11 of life. After clinical and radiological diagnosis of intestinal obstruction and failure to resolve with conservative management, laparotomy was done which revealed multiple inter bowel loop adhesions and an omental band adherent to distal ileum. On exploration, a localised abscess was seen around the gall bladder , a 0.5cm diameter perforation in the gall bladder. Exploratory laparotomy with cholecystectomy was done. The other two neonates presented with similar features and exploratory laparotomy with cholecystectomy was done. Perforation of the gall bladder is a rare cause of neonatal intestinal obstruction. The management is surgical and cholecystectomy or sewing the perforation should depend on the size of the perforation and the extent of peritonitis

5.
Indian Pediatr ; 2012 February; 49(2): 149-150
Article Dans Anglais | IMSEAR | ID: sea-169213

Résumé

We report a female neonate, who presented with abdominal distension and failure to pass meconium. Antenatal ultrasound at 32 weeks gestation and postnatal ultrasound on day1 suggested intestinal obstruction. During laparatomy, atresia of distal jejunum was found. The lumen of the distal segment contained an intussusceptum. Resection of the blind ends was done and end-to-end anastomosis was performed.

6.
Article Dans Anglais | IMSEAR | ID: sea-138670

Résumé

Congenital cystic adenomatoid malformation (CCAM) encompasses a continuum of hamartomatous cystic lung lesions characterised by the presence of abnormal bronchiolar structures of varying sizes or distribution. The CCAM is a disorder of infancy with majority of the cases being diagnosed within the first two years of life. We describe CCAM in a 13-yearold girl complaining of recurrent lower respiratory tract infections since infancy who presented with post-infectious pneumatocele with loculated pleural effusion, and suspected abscess formation and had undergone resection.


Sujets)
Adolescent , Malformation congénitale kystique adénomatoïde du poumon/complications , Malformation congénitale kystique adénomatoïde du poumon/diagnostic , Malformation congénitale kystique adénomatoïde du poumon/chirurgie , Diagnostic différentiel , Femelle , Humains , Abcès du poumon/diagnostic , Abcès du poumon/étiologie , Abcès du poumon/chirurgie , Photomicrographie , Épanchement pleural/diagnostic , Épanchement pleural/étiologie , Épanchement pleural/chirurgie , Radiographie thoracique , Thoracotomie/méthodes , Tomodensitométrie
7.
Indian J Pathol Microbiol ; 2009 Oct-Dec; 52(4): 598-599
Article Dans Anglais | IMSEAR | ID: sea-141576
8.
Indian Heart J ; 2008 Mar-Apr; 60(2): 101-19
Article Dans Anglais | IMSEAR | ID: sea-4664

Résumé

AIM: To evaluate the efficacy of the PercuSurge Guardwire(R) Plus Temporary Occlusion and Aspiration System, the actual procedural time involved and long-term follow-up in acute MI patients undergoing primary/rescue percutaneous coronary intervention (PCI). METHODS & RESULTS: It was a single centred, prospective study in 67 prospective AMI patients undergoing PCI. They were divided randomly into two groups depending on whether PercuSurge was used (n=30) or not used (control n=37) during PCI. Final TIMI flow, TMP grade and the time involved in or necessary for various steps of the PCI were recorded. PercuSurge showed significantly greater achievement of TIMI III flow and TMP III grade (p<0.01). Its use was associated with less total procedural time (p<0.05). The time required from guidewire crossing to stent placement; from guidewire crossing to TIMI III flow and from predilatation/stent placement to optimal TIMI flow was significantly reduced with its use (p<0.05 for all). Slow/no-reflow was significantly reduced (p<0.001), thus reducing intracoronary vasodilators and GP IIb/IIIa antagonists requirements. A 2 years' follow-up revealed four deaths in control and one death in PercuSurge group. CONCLUSION: PercuSurge reduced the total procedural time with better and faster optimal TIMI flow and TMP grade in primary/rescue PCI and was associated with less long term events.


Sujets)
Angioplastie coronaire par ballonnet , Études cas-témoins , Cathétérisme , Coronarographie , Femelle , Occlusion du greffon vasculaire/prévention et contrôle , Humains , Mâle , Adulte d'âge moyen , Infarctus du myocarde/thérapie , Revascularisation myocardique/méthodes , Études prospectives , Facteurs de risque , Thromboembolie/prévention et contrôle , Facteurs temps
9.
Indian Heart J ; 2004 Mar-Apr; 56(2): 110-6
Article Dans Anglais | IMSEAR | ID: sea-2780

Résumé

BACKGROUND: Patients with rheumatic heart disease and atrial fibrillation incur significant morbidity and mortality. It is not known which approach, rate control or maintenance of sinus rhythm might be most appropriate. The present study was undertaken to compare the strategy of ventricular rate control versus maintenance of sinus rhythm in rheumatic atrial fibrillation, and to evaluate the role of amiodarone in this patient population. METHODS AND RESULTS: We prospectively studied 144 patients with chronic rheumatic atrial fibrillation in a double-blind protocol-rhythm control (group I: 48 patients each with amiodarone -group Ia; and placebo -group Ib) and compared the effects with the ventricular rate control (group II) by diltiazem (n=48, open-label). Direct current cardioversion was attempted in group I. The mean age of the study population was 38.6+/-10.3 years, left atrial size was 4.7+/-0.6 cm, atrial fibrillation duration was 6.1+/-5.4 years, and 72.9% patients had undergone valvular interventions. At 1 year, 45 patients with sinus rhythm in group I compared to 48 patients in group II demonstrated significant increase in exercise to sinus rhythm time, had improvement in functional class and quality of life score. There was no difference in hospitalization rates, systemic bleeds or incidence of thromboembolism. Five patients died in group II but none in group I (p=0.02). In group I, 73/87 (83.9%) patients converted, and 45/86 (52.3%) patients maintained sinus rhythm at 1 year. Conversion rates were 38/43 (88.4%) with amiodarone versus 34/44 (77.3%) with placebo (p=0.49): corresponding rate for maintaining sinus rhythm was 29/42 (69.1%) versus 16/44 (36.4%), p=0.008 respectively. CONCLUSIONS: Maintenance of sinus rhythm appeared to be superior to ventricular rate control in patients with rheumatic atrial fibrillation in terms of an effect on mortality and morbidity. Sinus rhythm could be restored in the majority and amiodarone was superior to placebo in this regard.


Sujets)
Adulte , Amiodarone/administration et posologie , Antiarythmiques/administration et posologie , Fibrillation auriculaire/diagnostic , Maladie chronique , Diltiazem/administration et posologie , Relation dose-effet des médicaments , Méthode en double aveugle , Calendrier d'administration des médicaments , Électrocardiographie , Femelle , Humains , Mâle , Adulte d'âge moyen , Probabilité , Pronostic , Études prospectives , Valeurs de référence , Rhumatisme cardiaque/complications , Appréciation des risques , Indice de gravité de la maladie , Taux de survie , Résultat thérapeutique
SÉLECTION CITATIONS
Détails de la recherche